Teleconsultation is one of the few feasible options with good effectiveness for providing medical advice to children with epilepsy during pandemic times.
Explore recent news, including FDA-approval for a new Dravet syndrome treatment, a warning about mental health in patients who experience hallucinations, and the potential therapeutic benefits of Mozart.
Sirolimus has a significant effect on seizures associated with tuberous sclerosis complex (TSC), with no or only moderate adverse events after long-term administration.
Patient quality of life, depression and medication side effects were associated with caregiver burden.
Perampanel and brivaracetam are effective for the add-on treatment of focal-onset seizures and display similar adverse event profiles.
As innovations in neurotechnology for epilepsy emerge, understanding of individual and societal values is essential to their beneficial evolution and translation to care.
Current CURE Grantees are finding ways to continue their studies, but with severe restrictions on laboratory access, many researchers have had to limit or stop their work.
Compared with those with epileptic seizures, patients and caregivers living with PNES experience stigma more frequently and to a higher extent.
Safety was similar and clinical seizure outcomes exceeded those of the prospective clinical trials, corroborating effectiveness of this therapy and suggesting that clinical experience has informed more effective programming of the RNS device.
